Did the research evaluate CONVENIENCE or treatment response?If it evaluated treatment response (which it did), how did we arrive at CONVENIENCE as an outcome? Ok, to be fair with the researchers, they didn't do that. They mention it coz its obvious, right?Anyhow, if we are comparing this to Cu6 products: is Pluvicto (or cousin of Pluvicto) a DIAGNOSTIC or a THERAPY (treatment)?Since it's a therapy, why would you hang around for an extra day if there is nothing more to gain? Yep! That is my definition of inconvenience! So, in this study, what they did proved really inconvenient!
Why even wait at all, if tge imaging misses lesions up to 2cm in size! A plain Xray will pick that up easily! That's inconvenience!
Anyhow: it's only an abstract. Perhaps we will het more!
Did the research evaluate CONVENIENCE or treatment response?If...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.52 |
Change
0.130(5.44%) |
Mkt cap ! $810.1M | |||
| Open | High | Low | Value | Volume |
| $2.39 | $2.54 | $2.37 | $5.141M | 2.072M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6820 | $2.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.52 | 3500 | 1 |
View Market Depth
| Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |